<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00266448</url>
  </required_header>
  <id_info>
    <org_study_id>94/2000</org_study_id>
    <secondary_id>Projekt-Nr. 384/2000</secondary_id>
    <nct_id>NCT00266448</nct_id>
  </id_info>
  <brief_title>Whole Body Washing With Chlorhexidine for the Eradication of MRSA</brief_title>
  <official_title>The Value of Whole Body Washing With Chlorhexidine for the Eradication of MRSA - a Randomized, Placebo-Controlled, Double-Blinded Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether whole body washing with chlorhexidine in&#xD;
      combination with mupirocine nasal ointment is effective in the eradication of&#xD;
      meticillin-resistant Staphylococcus aureus (MRSA).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The number and rate of infections due to meticillin-resistant Staphylococcus aureus (MRSA)is&#xD;
      increasing world wide. Patients who are colonized with MRSA are the main source for further&#xD;
      distribution. In addition colonization with MRSA is a precondition for infection.&#xD;
&#xD;
      Whole body washing with antiseptic solutions as part of eradication strategies for MRSA has&#xD;
      been widely used. However, there is insufficient evidence to support use of topical&#xD;
      antimicrobial therapy for eradicating of MRSA because treatment with antiseptic solution has&#xD;
      never been compared to placebo.&#xD;
&#xD;
      Comparison: The efficacy of whole body washing in the control of MRSA was studied in a&#xD;
      randomized, placebo-controlled, double-blinded clinical trial. The study treatment consisted&#xD;
      of five days of whole body washing either with 4% chlorhexidine solution (verum) or with&#xD;
      placebo. All patients received mupirocin nasal ointment and chlorhexidine mouth rinse. The&#xD;
      outcome was evaluated 3, 4, 5, 9 and 30 days after treatment by swabs taken from several body&#xD;
      site.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2001</start_date>
  <completion_date>April 2004</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>efficacy of a whole body treatment with chlorhexidine in eradicating overall MRSA carriage</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>development of MRSA infection</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tolerance to the antiseptic whole body treatment</measure>
  </secondary_outcome>
  <enrollment>100</enrollment>
  <condition>MRSA-Colonization</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chlorhexidine solution 4%</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  persons who are colonized with MRSA, i.e. one or more cultures from any body site&#xD;
             yielded MRSA&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ongoing systemic or local antimicrobial treatment directed against MRSA&#xD;
&#xD;
          -  hypersensitivity to mupirocin or chlorhexidine&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  previous enrolment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Constanze Wendt, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hygiene-Institut University Hospital Heidelberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2004</verification_date>
  <study_first_submitted>December 15, 2005</study_first_submitted>
  <study_first_submitted_qc>December 15, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2005</study_first_posted>
  <last_update_submitted>December 15, 2005</last_update_submitted>
  <last_update_submitted_qc>December 15, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2005</last_update_posted>
  <keyword>MRSA</keyword>
  <keyword>eradication</keyword>
  <keyword>chlorhexidine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

